Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients.

Int J Crit Illn Inj Sci 2014 Apr;4(2):108-13

Intensive Care Unit and Burn Centre, University Hospital, Liège, Belgium.

Background: Hypermetabolism and hyposomatotropism related to severe burns lead to impaired wound healing. Growth hormone (GH) boosts wound healing notably following stimulation of the production of insulin-like growth factor-1 (IGF1), a mitogen factor for keratinocytes. Gamma-hydroxybutyrate (GHB) stimulates endogenous GH secretion.

Aim: To assess effects of GHB sedation on keratinocytes proliferation (based on immunohistochemical techniques).

Design: Monocentric, prospective, controlled trial.

Materials And Methods: Patients (aging 18-65 years, burn surface area >30%, expected to be sedated for at least one month) were alternately allocated, at the 5(th) day following injury, in three groups according to the intravenous GHB dose administered for 21 days: Evening bolus of 50 mg/kg (Group B), continuous infusion at the rate of 10 mg/kg/h (Group C), or absence of GHB (Group P). They all received local standard cares. Immunohistochemistry (Ki67/MIB-1, Ulex europaeus agglutinin-1 and Mac 387 antibodies) was performed at D21 on adjacent unburned skin sample for assessing any keratinocyte activation. Serum IGF1 levels were measured at initiation and completion of the protocol.

Statistical Analysis: Categorical variables were compared with Chi-square test. Comparisons of medians were made using Kruskal-Wallis test. Post hoc analyses were performed using Mann-Whitney test with Bonferroni correction for multiple comparisons. A P < 0.05 was considered to be statistically significant.

Results: A total of 14 patients completed the study (Group B: n = 5, Group C: n = 5, Group P: n = 4). Continuous administration of GHB was associated with a significant higher Ki67 immunolabeling at D21 (P = 0.049) and with a significant higher increase in the IGF1 concentrations at D21 (P = 0.024). No adverse effects were disclosed.

Conclusions: Our preliminary data support a positive effect of GHB on keratinocyte proliferation and are encouraging enough to warrant large prospective studies.

Download full-text PDF

Source
http://dx.doi.org/10.4103/2229-5151.134150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093961PMC
April 2014
13 Reads

Publication Analysis

Top Keywords

group continuous
8
keratinocytes proliferation
8
wound healing
8
prospective controlled
8
group group
8
group
6
ghb
6
adjacent unburned
4
skin sample
4
d21 adjacent
4
unburned skin
4
387 antibodies
4
europaeus agglutinin-1
4
ulex europaeus
4
agglutinin-1 mac
4
mac 387
4
antibodies performed
4
performed d21
4
assessing keratinocyte
4
completion protocolstatistical
4

Similar Publications